Ribon Therapeutics (@RibonTx) / X

PDF) Enabling Drug Discovery for the PARP Protein Family through the Detection of Mono-ADP-Ribosylation

Articles about Ribon Therapeutics

Molecules, Free Full-Text

Ribon Therapeutics on X: Today, we warmly welcome Paul Brannelly to the Ribon team as our Chief Financial Officer. Paul is a biopharma industry veteran with over 20 years of leadership experience.

Molecules, Free Full-Text

New directions in poly(ADP‐ribose) polymerase biology - Bock - 2016 - The FEBS Journal - Wiley Online Library

Leadership – Ribon Therapeutics

Ribon Therapeutics (@RibonTx) / X

Investors – Ribon Therapeutics

Investors – Ribon Therapeutics

RCSB PDB - 6V3W: Human Poly(ADP-Ribose) Polymerase 12, Catalytic fragment with four point mutations in complex with RBN-2397

Articles about Ribon Therapeutics

Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule - Wigle - 2021 - ChemBioChem - Wiley Online Library

Leadership – Ribon Therapeutics